Rapid Micro Biosystems RPID Product — Total Cost of Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Rapid Micro Biosystems in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapid Micro Biosystems's product — total cost of revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rapid Micro Biosystems's product — total cost of revenue?
- Rapid Micro Biosystems (RPID) reported product — total cost of revenue of $6.03M in Q1 2026.
- How has Rapid Micro Biosystems's product — total cost of revenue changed year-over-year?
- Rapid Micro Biosystems's product — total cost of revenue increased by 19.8% year-over-year, from $5.03M to $6.03M.
- What is the long-term trend for Rapid Micro Biosystems's product — total cost of revenue?
- Over 4 years (2021 to 2025), Rapid Micro Biosystems's product — total cost of revenue has grown at a 2.6% compound annual growth rate (CAGR), from $23.43M to $25.98M.
- What does product — total cost of revenue mean?
- This metric captures the direct costs associated with manufacturing, sourcing, and delivering the physical products sold by a specific business segment. It includes expenses such as raw materials, direct labor, and overhead directly attributable to the production process. Monitoring this metric is essential for evaluating the production efficiency and gross margin potential of the company's product portfolio.